Quantinno Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.3M | Buy |
260,188
+66,910
| +35% | +$5.23M | 0.09% | 252 |
|
2025
Q1 | $14M | Buy |
193,278
+32,042
| +20% | +$2.32M | 0.09% | 253 |
|
2024
Q4 | $11.9M | Buy |
161,236
+108,053
| +203% | +$8M | 0.12% | 162 |
|
2024
Q3 | $3.51M | Buy |
53,183
+12,028
| +29% | +$794K | 0.05% | 519 |
|
2024
Q2 | $3.8M | Sell |
41,155
-4,223
| -9% | -$390K | 0.07% | 339 |
|
2024
Q1 | $4.34M | Buy |
45,378
+35,161
| +344% | +$3.36M | 0.09% | 231 |
|
2023
Q4 | $779K | Sell |
10,217
-10,250
| -50% | -$782K | 0.03% | 698 |
|
2023
Q3 | $1.42M | Sell |
20,467
-12,794
| -38% | -$886K | 0.06% | 413 |
|
2023
Q2 | $3.14M | Buy |
33,261
+12,529
| +60% | +$1.18M | 0.18% | 103 |
|
2023
Q1 | $1.72M | Buy |
20,732
+2,792
| +16% | +$231K | 0.11% | 232 |
|
2022
Q4 | $1.34M | Buy |
17,940
+14,925
| +495% | +$1.11M | 0.1% | 293 |
|
2022
Q3 | $249K | Buy |
3,015
+218
| +8% | +$18K | 0.03% | 532 |
|
2022
Q2 | $266K | Buy |
+2,797
| New | +$266K | 0.04% | 487 |
|
2020
Q2 | – | Sell |
-9,876
| Closed | -$621K | – | 352 |
|
2020
Q1 | $621K | Buy |
+9,876
| New | +$621K | 0.39% | 70 |
|